Role of Stem Cells in Human Uterine Leiomyoma Growth
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Uterine leiomyoma is the most common benign tumor in reproductive-age women. Each leiomyoma is thought to be a benign monoclonal tumor arising from a single transformed myometrial smooth muscle cell; however, it is not known what leiomyoma cell type is responsible for tumor growth. Thus, we tested the hypothesis that a distinct stem/reservoir cell-enriched population, designated as the leiomyoma-derived side population (LMSP), is responsible for cell proliferation and tumor growth. PRINCIPAL FINDINGS: LMSP comprised approximately 1% of all leiomyoma and 2% of all myometrium-derived cells. All LMSP and leiomyoma-derived main population (LMMP) but none of the side or main population cells isolated from adjacent myometrium carried a mediator complex subunit 12 mutation, a genetic marker of neoplastic transformation. Messenger RNA levels for estrogen receptor-α, progesterone receptor and smooth muscle cell markers were barely detectable and significantly lower in the LMSP compared with the LMMP. LMSP alone did not attach or survive in monolayer culture in the presence or absence of estradiol and progestin, whereas LMMP readily grew under these conditions. LMSP did attach and survive when directly mixed with unsorted myometrial cells in monolayer culture. After resorting and reculturing, LMSP gained full potential of proliferation. Intriguingly, xenografts comprised of LMSP and unsorted myometrial smooth muscle cells grew into relatively large tumors (3.67 ± 1.07 mm(3)), whereas xenografts comprised of LMMP and unsorted myometrial smooth muscle cells produced smaller tumors (0.54 ± 0.20 mm(3), p<0.05, n = 10 paired patient samples). LMSP xenografts displayed significantly higher proliferative activity compared with LMMP xenografts (p<0.05). CONCLUSIONS: Our data suggest that LMSP, which have stem/reservoir cell characteristics, are necessary for in vivo growth of leiomyoma xenograft tumors. Lower estrogen and progesterone receptor levels in LMSP suggests an indirect paracrine effect of steroid hormones on stem cells via the mature neighboring cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For the stimulation of clonal expansion and growth of leiomyoma, sex steroids and steroid hormone receptors are necessary; yet, leiomyoma stem cells express barely detectable levels of ESR1 or PGR (Mas et al., 2012;Ono et al., 2012).”
From Endometriosis and nuclear receptors (2019) · cites this paper as Ono et al., 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The relationship between the spleen colony-forming cell and the haemopoietic stem cell.
Schofield, R. (1978) · PubMed · Cited by 2,333
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche
Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh, G. Y., & Suda, T. (2004) · Cell · doi:10.1016/j.cell.2004.07.004 · Cited by 1,974
Jordan, C. T., Guzman, M. L., & Noble, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra061808 · Cited by 1,702
Stewart, E. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03622-9 · Cited by 1,031
Etiology, symptomatology, and diagnosis of uterine myomas
Parker, W. H. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.01.093 · Cited by 721 · cited 1×
“Several recurrent genetic aberrations, such as trisomy of chromosome 12, deletions in 7q, and mutation affecting the mediator complex subunit 12 (MED12) or the high mobility group AT-hook 2 (HMGA2) gene were reported in uterine leiomyomas [15,16,17,18].”
BackgroundControl of mammary stem cell function by steroid hormone signalling
Asselin-Labat, M.-L., Vaillant, F., Sheridan, J. M., Pal, B., Wu, D., Simpson, E. R., Yasuda, H., Smyth, G. K., Martin, T. J., Lindeman, G. J., et al. (2010) · Nature · doi:10.1038/nature09027 · Cited by 693 · cited 1×
“In mammary structures of humans and mice, mammary stem cells, despite being void of ESR1 and PGR themselves, are subject to regulation in both number and repopulating ability by steroid hormones, particularly progesterone [40,41,42,43].”
BackgroundProgesterone induces adult mammary stem cell expansion
Joshi, P. A., Jackson, H. W., Beristain, A. G., Di Grappa, M. A., Mote, P. A., Clarke, C. L., Stingl, J., Waterhouse, P. D., & Khokha, R. (2010) · Nature · doi:10.1038/nature09091 · Cited by 689 · cited 1×
“In mammary structures of humans and mice, mammary stem cells, despite being void of ESR1 and PGR themselves, are subject to regulation in both number and repopulating ability by steroid hormones, particularly progesterone [40,41,42,43].”
BackgroundMED12 , the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas
Mäkinen, N., Mehine, M., Tolvanen, J., Kaasinen, E., Li, Y., Lehtonen, H. J., Gentile, M., Yan, J., Enge, M., Taipale, M., et al. (2011) · Science · doi:10.1126/science.1208930 · Cited by 658 · cited 3×
“MED12 mutations demonstrate that LMSP are committed to a leiomyoma cell lineage Recently, mutations in the MED12 gene have been reported in the majority of leiomyoma tissues and cells [16].”
BackgroundUterine Fibroids: The Elephant in the Room
Walker, C. L., & Stewart, E. A. (2005) · Science · doi:10.1126/science.1112063 · Cited by 547 · cited 1×
“Uterine leiomyomas, the most common pelvic tumor in women, are benign smooth muscle tumors originating from the myometrium”
BackgroundUterine Myomas: An Overview of Development, Clinical Features, and Management
Wallach, E. E., & Vlahos, N. F. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000136079.62513.39 · Cited by 540 · cited 2×
“Uterine leiomyomas are also an important cause of infertility and they are the most common medical reason for hysterectomy [3,4].”
Background
Cited by
Bulun, S. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1209993 · Cited by 703
Self-citationStewart, E. A., Laughlin-Tommaso, S. K., Catherino, W. H., Lalitkumar, S., Gupta, D., & Vollenhoven, B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.43 · Cited by 531
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Self-citationMenstruation: science and society
Critchley, H. O. D., Babayev, E., Bulun, S. E., Clark, S., Garcia-Grau, I., Gregersen, P. K., Kilcoyne, A., Kim, J.-Y. J., Lavender, M., Marsh, E. E., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.06.004 · Cited by 448
Self-citationComprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment
Yang, Q., Ciebiera, M., Bariani, M. V., Ali, M., Elkafas, H., Boyer, T. G., & Al-Hendy, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab039 · Cited by 425
Metadata
- Authors
- Ono, M., Qiang, W., Serna, V. A., Yin, P., Coon, J. S., Navarro, A., Monsivais, D., Kakinuma, T., Dyson, M., Druschitz, S., Unno, K., Kurita, T., & Bulun, S. E.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Bulun, Serdar E.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-03
- Volume
- 7
- Issue
- 5
- Pages
- e36935
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3343011
- OpenAlex
- W2046521626
- Semantic Scholar
- 546a83c8bc3366b826a6171706241d9b4ac6c215
- Cited by
- 141
- References
- 45
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 9 · 2020: 14 · 2019: 9 · 2018: 16 · 2017: 9 · 2016: 10 · 2015: 15 · 2014: 16 · 2013: 10
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Northwestern University (CA060553, NCI CA060553)
- National Institutes of Health (CA-060553, NCI CA060553)
- National Cancer Institute (CA 060553, NCI CA060553, R01CA154358, P30CA060553)
- National Institute of General Medical Sciences (R25GM079300)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01HD057877, R01HD064402)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Urology › Urologic and reproductive health conditions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- uterine fibroids, stem cells, side population cells, tumor growth, myometrium, estrogen receptor alpha, progesterone receptor, smooth muscle cells, xenografts, steroid hormone signaling, paracrine effects, oncogenic transformation
- MeSH terms
- Adult, Animals, Antigens, Surface, Base Sequence, Blood Cells, Bone Marrow Cells, Cell Cycle, Cell Differentiation, Cell Transformation, Neoplastic, Female, Humans, Leiomyoma, Middle Aged, Mutation, Myometrium, Neoplastic Stem Cells, Uterine Neoplasms, Mice, SCID, Mice, Inbred NOD, Coculture Techniques, Cell Lineage, Myocytes, Smooth Muscle, Cell Proliferation, Mice, Mediator Complex, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of Stem Cells in Human Uterine Leiomyoma Growth. https://app.cochat.ai/papers/10.1371/journal.pone.0036935
- The paper
- Ono, M., Qiang, W., Serna, V. A., Yin, P., Coon, J. S., Navarro, A., Monsivais, D., Kakinuma, T., Dyson, M., Druschitz, S., Unno, K., Kurita, T., & Bulun, S. E. (2012). Role of Stem Cells in Human Uterine Leiomyoma Growth. PLoS ONE. https://doi.org/10.1371/journal.pone.0036935
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.